Circassia Pharma (CIR.L) - specialty pharmaceutical company focused on respiratory disease transferring from the Main Market. No funds being raised. Due 4 Feb.
Greenfields Petroleum (TSX-V:GNF) production focused company with operated assets in Azerbaijan seeking AIM dual listing including $60m private placement. Mkt cap $12.6m CAD. Expected late January 2019.

15 Jan 2019
Small Cap Feast
Itaconix plc (ITX:LON), 102 | Gym Group Plc (GYM:LON), 147 | Forterra Plc (FORT:LON), 188 | Eden Research plc (EDEN:LON), 2.6 | Silence Therapeutics plc (SLNCF:OTC), 0 | Tlou Energy Ltd (55L:FRA), 0

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Small Cap Feast
Itaconix plc (ITX:LON), 102 | Gym Group Plc (GYM:LON), 147 | Forterra Plc (FORT:LON), 188 | Eden Research plc (EDEN:LON), 2.6 | Silence Therapeutics plc (SLNCF:OTC), 0 | Tlou Energy Ltd (55L:FRA), 0
- Published:
15 Jan 2019 -
Author:
Derren Nathan - Pages:
-
Circassia Pharma (CIR.L) - specialty pharmaceutical company focused on respiratory disease transferring from the Main Market. No funds being raised. Due 4 Feb.
Greenfields Petroleum (TSX-V:GNF) production focused company with operated assets in Azerbaijan seeking AIM dual listing including $60m private placement. Mkt cap $12.6m CAD. Expected late January 2019.